Are Pharma Marketers Fighting the Last War?

In this ISSUE

Salarius Pharmaceuticals: Pursuing Unconventional Paths to Public Markets

FDA Will Miss Gottlieb's Leadership

Regulatory Reform in China: Q&A with Dr. Lingshi Tan

Top Story

Are Pharma Marketers Fighting the Last War?

If payers are the fastest growing influencers in healthcare (and they are), why is it that payer-targeted advertising campaigns are often an afterthought? Amber Gilbert reports
… /Read more/

Patient Adherence: A Hard Pill to Swallow?
Asia-Pacific: Thursday, April 11, 2019 at 11:30am IST | 2pm CST | 3pm JST
North America: Thursday, April 11, 2019 at 1pm EDT | 12pm CDT | 10am PDT

Strategy

How Gamification Can Help Pharma Companies Play to Win

Applying game mechanics to healthcare marketing efforts has significant potential to ensure that patients are activated, educated and engaged throughout the duration of their care, which could drive business impact and improve patient outcomes
… /Read more/

Pricing

The Patient Comes First with Outcomes–Based Contracting

Nate Taninecz discusses benefits and challenges of OBC
… /Read more/

Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
Wednesday, March 20, 2019 at 1pm EDT | 12pm CDT | 10am PDT

Technology

The Implications of Connected Medical Devices & Digital Healthcare

Loetitia Jabri considers the broader implications as healthcare providers embraces new digital connectivity options as part of the Medicine 2.0 era
… /Read More/

Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
Tuesday, March 19, 2019 at 6pm EDT

Calendar

/ March 12–13: Pharmaceutical Compliance Congress Asia /

Shanghai, China

/ March 12–13: e-Rx and EHR 2019 /

Philadelphia, PA

/ March 12–14: 17^th Annual eyeforpharma Barcelona /

Barcelona, Spain

/ March 18–21: DCAT Week '19 /

New York City, NY

/ March 20–22: 15^th Life Sciences Accounting and Reporting Congress /

Philadelphia, PA

/ March 20–March 21: Partnering with IDNs Biopharma Strategy Summit West /

Scottsdale, AZ

/ March 27–28: 12^th Annual Expanded Access Programs /

Philadelphia, PA

/ June 12–13: Rare Disease Innovation and Partnering Summit /

Boston, MA

Technology

Planning Ahead with J&J's Global Head Executive Search

Michael Wong interviews J&J's Caitlin Hadtke Gagnon
… /Read More/

The Pharm Exec Podcast: Patient Advocacy at Eloxx Pharmaceuticals

Pharm Exec editors sit down with Bob Ward, chairman and CEO of Eloxx Pharmaceuticals, to talk about his personal, as well as Eloxx's, commitment to working with patient advocacy groups, how to attract talent, and how to put together a great team
… /Click here to listen/

Industry update

//Codexis (Redwood City, CA) appointed Laurie Heilmann as Senior Vice President of Business Development and Marketing. // Sarah Cooley, M.D., M.S. joined Fate Therapeutics (San Diego, CA) as Senior Vice President, Clinical Translation. // Molecular Templates (Austin, TX) appointed Roger J. Waltzman, M.D., as Chief Medical Officer. // Spring Bank (Hopkinton, MA) Pharmaceuticals appointed Atif Abbas, M.D. as Vice President, Head of Oncology & Immunology Clinical Development. // Aileron Therapeutics (Watertown, MA) named Kathryn Gregory as Chief Business Officer. // SHYFT Analytics (Waltham, MA) announced the addition of Bruno Lempernesse and Aaron Galaznik, M.D. to its real-World Evidence (RWE) team. Lempernesse will lead SHYFT's team supporting the biopharma and CRO evidence generation strategies of its partners, while Galaznik will lead a team working with customers and partners to support the growing RWE needs of customers. // EVERSANA (Chicago, IL) an independent provider of global services to the life science industry, announced three appointments to the executive leadership team. Greg Skalicky as Chief Revenue Officer; Tim Guttman as Chief Financial Officer; and Mark MacNaughton as Chief Information Officer,

advertise with us / print subscribe / digital subscribe / visit pharmexec.com